We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$39.8M
2
AGN
Allergan plc
AGN
+$27.2M
3
BID
Sotheby's
BID
+$17.1M
4
VSM
Versum Materials, Inc.
VSM
+$16.5M
5
ARRY
Array Biopharma Inc
ARRY
+$15.8M

Top Sells

Rank Stock Value
1
TVPT
Travelport Worldwide Limited
TVPT
+$27.8M
2
ULTI
Ultimate Software Group Inc
ULTI
+$19M
3
CNC icon
Centene
CNC
+$15M
4
LXFT
Luxoft Holding, Inc.
LXFT
+$14.7M
5
NAVG
Navigators Group Inc
NAVG
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCTL
1551
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3K ﹤0.01%
376
-56,780
-99% -$454K
CLVS
1552
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$3K ﹤0.01%
200
-100
-33% -$1.81K
XLRN
1553
DELISTED
Acceleron Pharma
XLRN
$3K ﹤0.01%
61
-3,048
-98% -$126K
ACMR icon
1554
ACM Research
ACMR
$5.46B
$2K ﹤0.01%
+300
New +$1.74K
AMR icon
1555
Alpha Metallurgical Resources
AMR
$1.93B
$2K ﹤0.01%
38
-11,551
-100% -$642K
EPM icon
1556
Evolution Petroleum
EPM
$127M
$2K ﹤0.01%
+300
New +$2.02K
GME icon
1557
GameStop
GME
$8.63B
$2K ﹤0.01%
1,216
-79,720
-98% -$156K
HRTX icon
1558
Heron Therapeutics
HRTX
$94.5M
$2K ﹤0.01%
121
-8,930
-99% -$178K
HSBC icon
1559
HSBC
HSBC
$352B
$2K ﹤0.01%
+51
New +$2.14K
IOVA icon
1560
CALL
Iovance Biotherapeutics
IOVA
$2.77B
$2K ﹤0.01%
+100
New +$1.51K
ITT icon
1561
ITT
ITT
$19.2B
$2K ﹤0.01%
+33
New +$2.02K
KALV
1562
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
69
-628
-90% -$14.7K
PBYI icon
1563
Puma Biotechnology
PBYI
$413M
$2K ﹤0.01%
120
-280
-70% -$6.45K
RIOT icon
1564
PUT
Riot Platforms
RIOT
$8.02B
$2K ﹤0.01%
+600
New +$2.38K
RVLV icon
1565
Revolve Group
RVLV
$1.75B
$2K ﹤0.01%
+59
New +$2.23K
SWK icon
1566
Stanley Black & Decker
SWK
$15.3B
$2K ﹤0.01%
16
-2,661
-99% -$375K
TG icon
1567
Tredegar Corp
TG
$270M
$2K ﹤0.01%
124
-11,668
-99% -$197K
TLRY icon
1568
Tilray
TLRY
$605M
$2K ﹤0.01%
5
– –
WW
1569
DELISTED
WW International
WW
$2K ﹤0.01%
+100
New +$1.98K
MRNS
1570
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
+125
New +$2.17K
MRNS
1571
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
+125
New +$2.17K
MRNS
1572
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
+125
New +$2.17K
EIGR
1573
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2K ﹤0.01%
5
-39
-89% -$13.5K
POLY
1574
DELISTED
Plantronics, Inc.
POLY
$2K ﹤0.01%
+50
New +$2.32K
TREC
1575
DELISTED
Trecora Resources
TREC
$2K ﹤0.01%
+200
New +$1.9K
61 62
63
64 65

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.